Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 11, 2023
Eurofins CDMO Alphora announced that it received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023.
read more
Headlands Research announced its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials.
read more
Wednesday, August 20, 2025
Headlands Research announced the opening of Headlands Research Twin Cities (HRTC), its 23rd fully owned site. Strategically situated in the Minneapolis–St. Paul metro area, the new center offers pharmaceutical sponsors and CROs rapid, single-contract...
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
Friday, February 19, 2021
Headlands Research has acquired Artemis Institute for Clinical Research.
read more
HCL Technologies Limited announced the acquisition of C3i Solutions, a multi-channel customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Hawkins has announced that it recently completed its acquisition of Stauber Performance Ingredients from ICV Partners II, L.P. and its other shareholders in a cash for stock transaction.
read more
Wednesday, November 12, 2014
announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms ...
read more
Guadalupe, Nuevo Leon, Harmonic Nature is voluntarily recalling all 800 bottles Hand Sanitizer, 250mL, product due to the potential presence of 1-propanol.
read more
Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making low-cost naloxone available to everyone, and Catalent announced the signing of a commercial supply agreement.
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services(CRS) business, is prepared to meet the global demand for development programs in novel biologics and biosimilars.
read more
Thursday, August 22, 2013
A workshop to discuss ways of improving the quality of drugs entering into the preclinical stage of development will be led by Ciriaco Maraschiello, PhD, director of drug discovery and translational medicines for Harlan Contract Research Services (...
read more
Thursday, August 08, 2013
Harlan Contract Research Services (CRS) Cytotest Cell Research GmbH in Rossdorf, Germany, has been named one of the first laboratories selected for inclusion in the European Union Network of Laboratories for the Validation of Alternative Methods (EU-...
read more
Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, 3.France, announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a ...
read more